Impax Laboratories Settles Pending Litigation for FLOMAX(R)
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Data from a head-to-head crossover study evaluating FOSRENOL
Fresenius Medical Care introduces programme for improved PD therapy
To keep up to date with news from this category use our ![]()
Cook Medical Drives Innovation and Education in the Field of Endourology at World Congress of Endourology
Bloomington, Ind., October 5, 2009 -- Continuing to drive innovation in endourology, Cook Medical will feature a series of product demonstrations and interactive presentations with a special emphasis on kidney stone...
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
HAYWARD, Calif., October 05, 2009 -- Impax Laboratories, Inc. (NASDAQ: IPXL) today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug...